Skip to content

A randomized, double-blind, placebo-controlled trial of the effects of green tea on lifestyle-related disease prevention 2009

A randomized, double-blind, placebo-controlled trial of the effects of green tea on lifestyle-related disease prevention 2009 - Effects of green tea on lifestyle-related disease prevention 2009

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003314
Enrollment
150
Registered
2010-03-11
Start date
2009-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome

Interventions

Ten capsules of Yabukita green tea extracts powder a day (1.8 g/day), for 12 weeks. Ten capsules of Benihuki green tea extracts powder a day (1.8 g/day), for 12 weeks. Ten capusules of placebo powder

Sponsors

Kakegawa city general hospital
Lead Sponsor
Tokoku University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From 30 years old to 70 years old and meets at least one of the followings; 1.BMI: 23 Kg/m2 or over 2.Total-cholesterol: 200 mg/dl or more 3.LDL-Cholesterol: 130mg/dl or more

Exclusion criteria

Exclusion criteria: 1) Individuals with a medical record of heart failure or cardiac infarction. 2) Individuals judged to have atrial fibrillation, Irregular Heart Beat, hepatic damage, kidney damage, cerebrovascular accident, rheumatism, diabetes mellitus, lipid disorder and/or anemia. 3) Individuals with a medical record of allergy to food and drug. 4) Pregnant women, or women with intending to become pregnant, and lactating women. 5) Individuals judged by the doctor to be unsuitable.

Design outcomes

Primary

MeasureTime frame
1) body weight 2) LDL-cholesterol

Secondary

MeasureTime frame
1) waist 2) Serum total cholesterol, HDL-cholesterol, triglycerides 3) FBS, HbA1c, insulin 4) Serum amyloid protein A, high sensitive C reactive protein 5) Adiponectin, TNF-alfa, urine 8-OHdG

Countries

Japan

Contacts

Public ContactMitsuhiro Yamada

Kakegawa city Health Protection Section

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026